EPISODE · Apr 16, 2024 · 59 MIN
Large Language Model-based Chatbots and Medical Regulation
from YaleUniversity · host YaleUniversity
Our guest is Prof. Stephen Gilbert (https://www.linkedin.com/in/stephen-gilbert-31ba2587/) who is a Professor of Medical Device Regulatory Science at the Else Kröner Fresenius Center for Digital Health, Technische Universität Dresden where he teaches and conducts research on regulatory science with a team of colleagues. He is also News and Views Editor, Nature Portfolio - Digital Health. He worked in senior MedTech and Digital Heath roles in industry for 5 years, before returning to academia in 2022. His research goals are to advance the regulatory science of software as a medical device and AI-enabled medical devices. Innovative digital approaches to healthcare must be accompanied by innovative approaches in regulation to ensure speed to market, to maximum access of patients to life saving treatments whilst ensuring safety on market. His main research interests are in: (i) data sharing and the European Health Data Space; (ii) approaches to market approval of adaptive AI enabled medical devices; (iii) drugdigital/AI-enabled medical device product realisation; (iv) digital/virtual twins: as an organising concept of the future of healthcare." Further Reading Derraz B, Breda G, Kaempf C, Baenke F, Cotte F, Reiche K, Köhl U, Kather JN, Eskenazy D, Gilbert S. New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology. NPJ Precis Oncol [Internet]. Nature Publishing Group; 2024 Jan 30 [cited 2024 Jan 30];8(1):1–11. Available from: https://www.nature.com/articles/s41698-024-00517-w Gilbert S, Harvey H, Melvin T, Vollebregt E, Wicks P. Large language model AI chatbots require approval as medical devices. Nat Med [Internet]. Nature Publishing Group; 2023 Jun 30 [cited 2023 Jun 30];1–3. Available from: https://www.nature.com/articles/s41591-023-02412-6 Gilbert S and Kather JN. Guardrails for the use of generalist AI in cancer care. Nature Reviews Cancer [Internet]. Nature Publishing Group; 2024 Apr 16 [cited 2024 Apr 16]. Available from: https://www.nature.com/articles/s41568-024-00685-8
What this episode covers
Our guest is Prof. Stephen Gilbert (https://www.linkedin.com/in/stephen-gilbert-31ba2587/) who is a Professor of Medical Device Regulatory Science at the Else Kröner Fresenius Center for Digital Health, Technische Universität Dresden where he teaches and conducts research on regulatory science with a team of colleagues. He is also News and Views Editor, Nature Portfolio - Digital Health. He worked in senior MedTech and Digital Heath roles in industry for 5 years, before returning to academia in 2022. His research goals are to advance the regulatory science of software as a medical device and AI-enabled medical devices. Innovative digital approaches to healthcare must be accompanied by innovative approaches in regulation to ensure speed to market, to maximum access of patients to life saving treatments whilst ensuring safety on market. His main research interests are in: (i) data sharing and the European Health Data Space; (ii) approaches to market approval of adaptive AI enabled medical devices; (iii) drugdigital/AI-enabled medical device product realisation; (iv) digital/virtual twins: as an organising concept of the future of healthcare." Further Reading Derraz B, Breda G, Kaempf C, Baenke F, Cotte F, Reiche K, Köhl U, Kather JN, Eskenazy D, Gilbert S. New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology. NPJ Precis Oncol [Internet]. Nature Publishing Group; 2024 Jan 30 [cited 2024 Jan 30];8(1):1–11. Available from: https://www.nature.com/articles/s41698-024-00517-w Gilbert S, Harvey H, Melvin T, Vollebregt E, Wicks P. Large language model AI chatbots require approval as medical devices. Nat Med [Internet]. Nature Publishing Group; 2023 Jun 30 [cited 2023 Jun 30];1–3. Available from: https://www.nature.com/articles/s41591-023-02412-6 Gilbert S and Kather JN. Guardrails for the use of generalist AI in cancer care. Nature Reviews Cancer [Internet]. Nature Publishing Group; 2024 Apr 16 [cited 2024 Apr 16]. Available from: https://www.nature.com/articles/s41568-024-00685-8
NOW PLAYING
Large Language Model-based Chatbots and Medical Regulation
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.